Cargando…

Comments on ‘Comparison of anticoagulation strategies for veno-venous ECMO support in acute respiratory failure’: the bitter truth about unfractionated heparin monitoring assays

Detalles Bibliográficos
Autores principales:	Moussa, Mouhamed Djahoum, Abou-Arab, Osama, Robin, Emmanuel, Vincentelli, André
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006337/ https://www.ncbi.nlm.nih.gov/pubmed/33781295 http://dx.doi.org/10.1186/s13054-021-03525-5

Ejemplares similares

Evaluation of Anti-Activated Factor X Activity and Activated Partial Thromboplastin Time Relations and Their Association with Bleeding and Thrombosis during Veno-Arterial ECMO Support: A Retrospective Study
por: Moussa, Mouhamed Djahoum, et al.
Publicado: (2021)

Comparison of anticoagulation strategies for veno-venous ECMO support in acute respiratory failure
por: Seeliger, Benjamin, et al.
Publicado: (2021)

Monitoring of Unfractionated Heparin in Severe COVID-19: An Observational Study of Patients on CRRT and ECMO
por: Streng, Alexander S., et al.
Publicado: (2020)

Comments on “Right ventricular failure in septic shock: characterization, incidence and impact on fluid responsiveness”: which parameter to assess right ventricular failure and venous congestion?
por: Abou-Arab, Osama, et al.
Publicado: (2021)

Post-Discharge Depression Status for Survivors of Extracorporeal Membrane Oxygenation (ECMO): Comparison of Veno-Venous ECMO and Veno-Arterial ECMO
por: Lin, Wan-Jung, et al.
Publicado: (2022)

Evaluation of anti-Xa levels in patients with venous thromboembolism within the first 48 h of anticoagulation with unfractionated heparin
por: Nguyen, Lily, et al.
Publicado: (2023)

Bleeding During Veno-Venous ECMO: Prevention and Treatment
por: Kalbhenn, Johannes, et al.
Publicado: (2022)

Veno-venous ECMO indications: more than respiratory support
por: Blandino Ortiz, Aaron, et al.
Publicado: (2019)

Time in the Therapeutic Range for Assessing Anticoagulation Quality in Patients Receiving Continuous Unfractionated Heparin
por: Ting, Clara, et al.
Publicado: (2018)

Monitoring Unfractionated Heparin in Adult Patients Undergoing Extracorporeal Membrane Oxygenation (ECMO): ACT, APTT, or ANTI-XA?
por: Nguyen, Tung Phi, et al.
Publicado: (2021)

Early hyperoxia and 28-day mortality in patients on venoarterial ECMO support for refractory cardiogenic shock: a bicenter retrospective propensity score-weighted analysis
por: Moussa, Mouhamed Djahoum, et al.
Publicado: (2022)

The efficacy and safety of low-molecular-weight heparin and unfractionated heparin in the treatment of cerebral venous sinus thrombosis
por: Afshari, Daryoush, et al.
Publicado: (2015)

Portal Vein Pulsatility as a Dynamic Marker of Venous Congestion Following Cardiac Surgery: An Interventional Study Using Positive End-Expiratory Pressure
por: Huette, Pierre, et al.
Publicado: (2021)

Unfractionated and low molecular weight heparin
por: Lima, Marcelo, et al.
Publicado: (2014)

Analysis of Leukocyte Recruitment in Continuous Veno-Venous Hemofiltration with Regional Citrate vs. Systemic Heparin Anticoagulation
por: Margraf, Andreas, et al.
Publicado: (2022)

Comparison between nafamostat mesilate and unfractionated heparin as anticoagulant during continuous renal replacement therapy
por: Makino, S, et al.
Publicado: (2015)

Portal Vein Pulsatility Index as a Potential Risk of Venous Congestion Assessed by Magnetic Resonance Imaging: A Prospective Study on Healthy Volunteers
por: Abou-Arab, Osama, et al.
Publicado: (2022)

Successful sleeve resection of bronchial carcinoid under veno‐venous ECMO
por: Kang, Min Kyun, et al.
Publicado: (2019)

The relationship between antithrombin administration and inflammation during veno-venous ECMO
por: Panigada, Mauro, et al.
Publicado: (2022)

Unfractionated heparin and mechanical thromboprophylaxis in hip arthroplasty
por: Garcia, Flávio Luís, et al.
Publicado: (2015)

Unfractionated heparin or low-molecular-weight heparin for venous thromboembolism prophylaxis after hepatic resection: A meta-analysis
por: Zhang, Wentao, et al.
Publicado: (2022)

Use of activated clotting time to monitor anticoagulation in patients receiving unfractionated heparin on renal replacement therapy
por: Bidwai, A, et al.
Publicado: (2011)

Monitoring Anticoagulation with Unfractionated Heparin on Renal Replacement Therapy. Which is the Best aPTT Sampling Site?
por: Anton, Florin Ioan, et al.
Publicado: (2020)

Unfractionated heparin versus nafamostat mesylate for anticoagulation during continuous kidney replacement therapy: an observational study
por: Kameda, Shinya, et al.
Publicado: (2023)

Heparin-free after 3000 IU heparin loaded in veno-venous ECMO supported acute respiratory failure patients with hemorrhage risk: a novel anti-coagulation strategy
por: Zhao, Yang-Chao, et al.
Publicado: (2022)

Transforming Anesthesia Data Into the Observational Medical Outcomes Partnership Common Data Model: Development and Usability Study
por: Lamer, Antoine, et al.
Publicado: (2021)

An international survey of nutrition practices in adult patients receiving veno-venous ECMO
por: Bear, DE, et al.
Publicado: (2015)

The use of double lumen cannula for veno-venous ECMO in trauma patients with ARDS
por: Gothner, Martin, et al.
Publicado: (2015)

Simple equations to predict the effects of veno‐venous ECMO in decompensated Eisenmenger syndrome
por: Bonnemain, Jean, et al.
Publicado: (2021)

Blood flow but not cannula positioning influences the efficacy of Veno-Venous ECMO therapy
por: Leoni, Massimiliano, et al.
Publicado: (2022)

Low molecular weight heparin versus unfractionated heparin in the management of cerebral venous thrombosis: A systematic review and meta-analysis
por: Qureshi, Anjum, et al.
Publicado: (2017)

Alternatives to standard unfractionated heparin for pediatric hemodialysis treatments
por: Davenport, Andrew
Publicado: (2012)

Impact of COVID-19 on monitoring of therapeutic unfractionated heparin
por: Adie, Sarah K., et al.
Publicado: (2020)

Quantitative Analysis of Impurities in Unfractionated Heparin of Bovine Origin
por: Workman, Wesley E., et al.
Publicado: (2020)

Differential Neutralization of Unfractionated Heparin and Enoxaparin by Andexanet Alfa
por: Lewis, Joseph, et al.
Publicado: (2022)

Resistance to unfractionated heparin in the ICU: evaluation and management options
por: Levy, Jerrold H., et al.
Publicado: (2023)

Correction: Unfractionated heparin versus nafamostat mesylate for anticoagulation during continuous kidney replacement therapy: an observational study
por: Kameda, Shinya, et al.
Publicado: (2023)

The economic impact of enoxaparin versus unfractionated heparin for prevention of venous thromboembolism in acute ischemic stroke patients
por: Pineo, Graham F, et al.
Publicado: (2012)

Veno-venous ECMO: a synopsis of nine key potential challenges, considerations, and controversies
por: Tulman, David B, et al.
Publicado: (2014)

Veno-venous ECMO during surgical repair of tracheal perforation: A case report
por: Antonacci, Filippo, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_pk8s578regu116998bfqav221c